Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptoms

Alessandro Armuzzi, Antonio Gasbarrini, Andrea Lupascu, Barbara De Pascalis, Emilia Carloni, Paolo Pola, Ec Lauritano

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Infliximab has been proven to be an effective therapy in a miscellany of rheumatic diseases and has been approved for the treatment of moderate-to-severe Crohn's disease with an inadequate response to conventional therapy and for the management of enterocutaneous fistulas. Data about the role of infliximab in ulcerative colitis are still controversial. Here, we report a case of a patient with sacroileitis and peripheral arthropathy associated with left-sided ulcerative colitis who achieved a sustained clinical remission after infliximab therapy.
Original languageEnglish
Pages (from-to)423-425
Number of pages3
JournalDIGESTIVE AND LIVER DISEASE
Volume36
DOIs
Publication statusPublished - 2004

Keywords

  • Antibodies, Monoclonal
  • Colitis, Ulcerative
  • Gastrointestinal Agents
  • Sacroiliac Joint
  • Synovitis

Fingerprint

Dive into the research topics of 'Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptoms'. Together they form a unique fingerprint.

Cite this